TERMINATION AND EQUITY CONVERSION AGREEMENTTermination and Equity Conversion Agreement • August 21st, 2014 • Compugen LTD • Biological products, (no disgnostic substances)
This agreement (the “Agreement”) is entered into as of August 20, 2014 by and between BAIZE INVESTMENTS (ISRAEL) LTD., a private company organized under the laws of Israel No. 51-430159-1, c/o – The Goldman Group, 55 St. Clair Avenue West, Suite 240, Toronto, Ontario, Canada M4V2Y (“Investor”), and COMPUGEN, Ltd., an Israeli corporation, having a place of business at 72 Pinchas Rosen, Tel Aviv, Israel (“Compugen” and collectively with Investor, the “Parties”).
